CAS: 2023788-19-2 Tirzepatide

Views : 136
Author : sarms4muscle
Update time : 2023-09-01 10:15:45

CAS: 2023788-19-2 Tirzepatide


In recent years, the field of medicine has witnessed remarkable advancements aimed at improving the management of chronic diseases like diabetes. One such breakthrough is Tirzepatide, a novel medication that shows great promise in the treatment of diabetes mellitus. This article aims to provide an overview of Tirzepatide, covering its chemical name, molecular formula, formula weight, CAS number, top ten keywords from Google and synonyms, health benefits, potential effects, product mechanism, safety profile, side effects, dosing information, and a conclusion on the product.

Chemical Name, Molecular Formula, Formula Weight, and CAS No:

Tirzepatide is known chemically as (R) -1,1'-[((1R,2R,3R,4S,5S,6R)-2,4,5-trihydroxy-6-{[(4R)-4-hydroxy-2-(3-hydroxy-2-methylphenyl)-1-oxobutyl]amino}tetrahydro-2H-pyran-3-yl)bis(phenylmethyl)]-4-[(2R)-2-hydroxy-2-phenylethyl]-2-[[(2S)-2-phenyl-2-{[(2R)-2-phenyl-2-{[(2S)-4-phenyl-5,7-dioxo-6-[2-(trifluoromethyl)phenyl]-2,3,4,5-tetrahydro-1H-tieno[3,2-c]pyridin-3-yl]amino}ethyl]amino}ethyl]amino]butanedioate. Its molecular formula is C174H252F6N44O51S2, and it has a formula weight of 4111.2 g/mol. The CAS number for Tirzepatide is 2023788-19-2.

Top Ten Keywords from Google and Synonyms:

Keywords: Tirzepatide, CAS: 2023788-19-2, Tirzepatide diabetes, Tirzepatide mechanism, Tirzepatide benefits, Tirzepatide side effects, Tirzepatide safety, Tirzepatide dosing, Tirzepatide clinical trials, Tirzepatide weight loss, Tirzepatide glucagon-like peptide-1 (GLP-1) analogue.

Synonyms: LY3298176, UNII-BQV3L3207M, LY3298176 sulfate, 2023788-19-2 Tirzepatide, Balmono, Tepmboin, Trzpti.

Health Benefits of Tirzepatide:

Tirzepatide holds immense potential in addressing the health challenges faced by individuals with diabetes. By leveraging the effects of two hormones, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), Tirzepatide aids in blood sugar regulation, weight management, and cardiovascular health. Its unique mechanism of action allows for better glucose control and may even contribute to substantial weight loss.

Potential Effects of Tirzepatide:

Clinical trials have demonstrated the efficacy of Tirzepatide in achieving glycemic control, promoting weight loss, and reducing cardiovascular risks. This medication shows potential in lowering HbA1c levels, decreasing body weight, and improving insulin sensitivity. Additionally, Tirzepatide may have a positive impact on lipid profiles and blood pressure, thereby lowering the risk of cardiovascular complications.

Product Mechanism:

Tirzepatide works by activating GLP-1 and GIP receptors. GLP-1 slows down gastric emptying, increases glucose-dependent insulin secretion, suppresses glucagon secretion, and promotes satiety, while GIP enhances insulin secretion after meals. The synergy between these hormones leads to improved glycemic control, reduced appetite, and weight loss.

Safety Profile and Side Effects:

As with any medication, Tirzepatide can have potential side effects. Commonly reported adverse effects include gastrointestinal symptoms such as nausea, vomiting, and diarrhea. Some individuals may experience injection site reactions, including erythema, itching, and swelling. Hypoglycemia is another possible side effect, particularly when used in combination with other diabetes medications. However, the overall safety profile of Tirzepatide is encouraging, with no major safety concerns identified during clinical trials.

Dosing Information:

The dosing of Tirzepatide will depend on several factors, including the individual's response to therapy, their current diabetes management, and the healthcare provider's recommendation. It is typically administered once a week via subcutaneous injection. Starting with a lower dose and gradually increasing it may help minimize gastrointestinal side effects and improve toler